CIK 0000109657 · Non-accelerated filer<br>Smaller reporting company
GT Biopharma, Inc.
Sign in to watch- Ticker
- GTBP
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 941620407
- Phone
- (800) 304-9888
- Business address
- 505 MONTGOMERY STREET, 10TH FLOOR, SAN FRANCISCO, CA, 94111
- Former names
- GT Biopharma, Inc., OXIS INTERNATIONAL INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 14 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2003-12-04 | DAVIS RICHARD A Director | Grant or award · stock option (right to buy) | +59,807 | $0.57 | $34K | 84,807 |
| 2003-11-26 | ROGERS RAY R CEO/Chairman of the Board | Gift | −10,000 | $0.54 | $5K | 1,687,988 |
| 2003-06-30 | HAUSMAN MARVIN S MD Director | Conversion · Prefered to Common Stock | +1,113,145 | 1,191,145 | ||
| 2003-06-30 | WOLF THOMAS M Director | Conversion · Preferred Stock to Common Stock | +332,845 | 433,626 |
Page 9 of 9 · 164 trades